Food plant-delivered cholera toxin B subunit for vaccination and immunotolerization

Advances in Experimental Medicine and Biology

Volumn 464, Issue , 1999, Pages 161-178

  Arakawa, T ^a   Yu, J ^a   Langridge, W H R ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CHOLERA TOXIN B SUBUNIT; GLUTAMATE DECARBOXYLASE; HYBRID PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INSULIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOENGINEERING; BIOREACTOR; CHOLERA; CONFERENCE PAPER; CONTROLLED STUDY; CROP; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; POTATO; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECOMBINANT DNA TECHNOLOGY; TRANSGENIC PLANT; VACCINE PRODUCTION;

ANIMALIA; EUKARYOTA; SOLANUM TUBEROSUM;

EID: 0033280218     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4729-7_13     Document Type: Conference Paper

References (73)

1. Expression of cholera toxin B subunit oligomers in transgenic potato plants
2. Efficacy of a food plant-based oral cholera toxin B subunit vaccine
3. Map-based cloning of a gene controlling omega-3 fatty acid desaturation in Arabidopsis
4. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous auroimmune diabetes
5. Transfer of the yeast salt tolerance gene HALI to Cucumis melo L. cultivars and in vitro evaluation of salt tolerance
6. Systemic tolerance and secretory immunity after oral immunization
7. Expression of the human milk protein, β-casein in transgenic potato plants
8. Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae OI infections in a cholera-endemic area
9. Field trial of oral cholera vaccines in Bangladesh: Serum vibriocidal and antitoxic antibodies as markers of the risk of cholera
10. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues
11. Assembly of an antibody and its derived antibody fragment in Nicotina and Arabidopsis
12. Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines
13. Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition
14. Type I diabetes mellitus: A chronic autoimmune disease
15. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin
16. Oral tolerance: A commentary
17. Bacterial luciferase alpha-beta fusion protein is fully active as a monomer and highly sensitive in vivo to elevated temperature
18. Special features of the priming process for a secretory IgA response: B-cell priming with cholera toxin
19. Role of gamma delta T cells in the regulation of mucosal IgA response and oral tolerance
20. Antitoxic immunity in experimental cholera: Comparison of immunity induced perorally and parenterally in mice
21. The arrangement of subunits in cholera toxin
22. ADP-ribosylation of membrane proteins catalyzed by cholera toxin: Basis of the activation of adenylate cyclase
23. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits
24. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and prostaglandin-E
25. Oral immunization with a recombinant bacterial antigen produced in transgenic plants
26. Coordinated assembly of multisubunit proteins: Oligomerization of bacterial enterotoxins in vivo and in vitro
27. Production of antibodies in transgenic plants
28. Conformation of protein secreted across bacterial outer membranes: A study of enterotoxin translocation from Vibrio cholerae
29. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems
30. The natural history of cow's milk protein allergy/intolerance
31. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding
32. A family of novel myb-related genes from the resurrection plant Craterostigma plantagineum are specifically expressed in callus and roots in response to ABA or desiccation
33. Optimizing oral vaccines: Induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant
34. Expression of de novo high-lysine alpha-helical coiled-coil proteins may significantly increase the accumulated levels of lysine in mature seeds of transgenic tobacco plants
35. Accumulation of type I fish antifreeze protein in transgenic tobacco is cold-specific
36. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein
37. Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-β1
38. Expression and assembly of functional bacterial luciferase in plants
39. Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes
40. Dual promoter of Agrobaterium tumefaciens mannopine synthase gene is regulated by plant growth hormones
41. Immunity of cholera in man: Relative role of antibacterial versus antitoxic immunity
42. Modes of expression and common structural features of the complete phenylalanine ammonia-lyase gene family in parsley
43. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens
44. IgA isotype restriction in the mucosal but not in the extramucosal immune response after oral immunizations with cholera toxin or cholera B subunit
45. Cholera antibody production in vitro by peripheral blood lymphocytes following oral immunization of humans and mice
46. Transgenic plants expressing autoantigens fed to mice to induce oral tolerance
47. Generation and assembly of secretory antibodies in plants
48. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice
49. Expression of hepatitis B surface antigen in transgenic plants
50. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response
51. MI pentasaccharide
52. Detection of genetically engineered plants by polymerase chain reaction (PCR) using the FLAVR SAVR tomato as an example
53. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering
54. Expression of a human lactoferrin cDNA in tobacco cells produces antibacterial protein(s)
55. Current studies on the identification of susceptibility genes for IDDM in NOD mice
56. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: A longitudinal study
57. A C-terminal signal prevents secretion of luminal ER proteins
58. MI
59. A serine-to-threonine substitution in the triazine herbicide-binding protein in potato cells results in atrazine resistance without impairing productivity
60. Structure of the amplified 5-enolpyruvylshikimate-3-phosphate synthase gene in glyphosate-resistant carrot cells
61. Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance
62. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit
63. Synthetic cryIIIA gene from Bacillus thuringiensis improved for high expression in plants
64. Interaction of cholera toxin and ganglioside G(M1)
65. Immunogenicity of transgenic plant-derived hepatitis B surface antigen
66. Insulin-dependent diabetes mellitus
67. Effects of oral administration of type II collagen on rheumatoid arthritis
68. Infant feeding in Finnish children less than 7 yr of age with newly diagnosed IDDM. Childhood diabetes in Finland study group
69. Diet, cow's milk protein antibodies and the risk of IDDM in Finnish children. Childhood diabetes in Finland study group
70. Vicilin with carboxy-terminal KDEL is retained in the endoplasmic reticulum and accumulates to high levels in the leaves of transgenic plants
71. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens
72. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis
73. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin